Search research articles
Contact Us
Filters
Showing results (211-220 of 238) with videos related to
Page
of 24
Sort By:
Clinical Genitourinary Cancer
|
July 1, 2022
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Journal for Immunotherapy of Cancer
|
April 8, 2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini, Massimo Di Maio, Olga Nigro, et al.
Clinical Genitourinary Cancer
|
September 26, 2022
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Gino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology
|
March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
Simon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
The Lancet. Digital Health
|
February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
Mathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Therapeutic Advances in Medical Oncology
|
November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Laia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 238) with videos related to
Sort By:
Page
of 24
Clinical Genitourinary Cancer
|
July 1, 2022
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, et al.
Journal for Immunotherapy of Cancer
|
April 8, 2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini, Massimo Di Maio, Olga Nigro, et al.
Clinical Genitourinary Cancer
|
September 26, 2022
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2023
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, et al.
Journal for Immunotherapy of Cancer
|
March 23, 2021
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Gino M Dettorre, Saoirse Dolly, Angela Loizidou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 24, 2022
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology
|
March 10, 2025
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab
Simon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, et al.
The Lancet. Digital Health
|
February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
Mathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
Therapeutic Advances in Medical Oncology
|
November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Laia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.
Page
of 24